ScholarGate
Assistent

Sammenlign metoder

Gjennomgå de valgte metodene side om side; rader som avviker, er uthevet.

Caco-2 cellepermeabilitetsanalyse×Patch-Clamp Elektrofysiologi×Populasjonsfarmakodynamisk modellering×
FagfeltFarmakologiFarmakologiFarmakologi
FamilieProcess / pipelineProcess / pipelineProcess / pipeline
Opprinnelsesår198919761992
OpphavspersonIngrid HidalgoErwin Neher and Bert SakmannLewis Sheiner and Stephen Roush
Typeabsorption screeningion channel screeningdose-response modeling
Opprinnelig kildeHidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96(3), 736-749. DOI ↗Neher, E., & Sakmann, B. (1976). Single-channel currents recorded from membrane of denervated frog muscle fibres. Nature, 260(5554), 799-802. DOI ↗Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗
AliasCaco-2 assay, intestinal permeability, ADME screeningpatch clamp, whole-cell recording, ion channel assayPopPD, population PD, hierarchical PD modeling
Relaterte333
SammendragThe Caco-2 assay is an in vitro model system using human colon carcinoma cell monolayers to screen drug intestinal permeability. Developed by Hidalgo and colleagues in 1989, Caco-2 cells differentiate into an epithelial barrier resembling intestinal mucosa, enabling rapid assessment of drug absorption potential and identification of transporter-mediated transport.Patch-clamp electrophysiology is a technique for measuring ionic currents through ion channels in cell membranes, developed by Neher and Sakmann in 1976. It enables direct observation of single-channel and whole-cell currents at millisecond resolution, making it essential for characterizing drug effects on ion channels and cardiac safety assessment.Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction.
ScholarGateDatasett
  1. v1
  2. 2 Kilder
  3. PUBLISHED
  1. v1
  2. 2 Kilder
  3. PUBLISHED
  1. v1
  2. 2 Kilder
  3. PUBLISHED

Gå til søk Last ned lysbilder

ScholarGateSammenlign metoder: Caco-2 Permeability · Patch-Clamp · Population Pharmacodynamics. Hentet 2026-06-19 fra https://scholargate.app/no/compare